Abiopharma

Clinical trial NCT07199634: start date: 2026-04-01 → 2026-08-01.

Clinical trial NCT06052995 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. start date: 2023-11-01 → 2024-10-15 3. completion date: 2025-02-01 → 2027-03-01 4. primary completion date: 2024-08-01 → 2026-10-01

Clinical trial NCT06010173 updates: 1. completion date: 2025-03-26 → 2025-05-06 2. primary completion date: 2025-03-26 → 2025-05-06

Clinical trial NCT05607732 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 45257 → 57738 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04015141: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT04396574: enrollment: 566 → 558 participants.

Clinical trial NCT07366658: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06280209 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-09-30 → 2027-04-14 3. primary completion date: 2026-09-30 → 2027-04-14 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07100925 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 20 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05144854: primary completion date: 2026-05-01 → 2025-10-20.